NCMAP
Noncompact myelin-associated protein
Also known as: C1orf130, FLJ42528, MP11, NCMAP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T1S8
- Gene
- NCMAP
- Ensembl
- ENSG00000184454
- Chromosome
- 1
- Canonical length
- 102 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be a structural constituent of myelin sheath. Predicted to be involved in peripheral nervous system myelin formation and positive regulation of myelination. Predicted to be located in plasma membrane. Predicted to be active in Schmidt-Lanterman incisure and paranode region of axon. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
102 residues, UniProt reviewed canonical sequence.
>Q5T1S8|NCMAP
1 MTTATPLGDT TFFSLNMTTR GEDFLYKSSG AIVAAVVVVV IIIFTVVLIL LKMYNRKMRT
61 RRELEPKGPK PTAPSAVGPN SNGSQHPATV TFSPVDVQVE TRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCMAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 8.1 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 8.1 nTPM
- salivary gland: 7.3 nTPM
- gallbladder: 6.9 nTPM
- duodenum: 4.7 nTPM
- stomach: 4.6 nTPM
- liver: 4.3 nTPM
Single-cell type
- tuft cells: 646 nCPM
- pancreatic duct cells: 159 nCPM
- breast lactating cells: 79 nCPM
- epididymal efferent duct absorptive cells: 76 nCPM
- schwann cells: 57 nCPM
- parietal cells: 57 nCPM
Immune cell
- basophil: 0.7 nTPM
- neutrophil: 0.3 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
Brain region
- white matter: 6.8 nTPM
- cerebellum: 6.1 nTPM
- cerebral cortex: 5.5 nTPM
- pons: 5.5 nTPM
- medulla oblongata: 4.9 nTPM
- hypothalamus: 4.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Noncompact myelin-associated protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCMAP as an antibody target. Whether an autoantibody or antibody against NCMAP could matter depends on whether native NCMAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCMAP is annotated at the cell surface, where native NCMAP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NCMAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...